Hospices Civils de Lyon: Hepatitis C trials

The registry lists 11 Hepatitis C studies with Hospices Civils de Lyon as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 3 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in FranceNot yet recruitingNCT07038863Not applicable
• Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment EfficacyCompletedNCT03348059
• Side Effects After Direct-acting Antiviral TreatmentCompletedNCT03346941
• Benefit of DAA Therapy in HCV Monoinfected and HIV-HCV Coinfected Patients With Mixed CryoglobulinemiaCompletedNCT03342261
• Impact of Sofosbuvir and Daclatasvir Concentration on HCV RNACompletedNCT03318887
• Direct-acting Antivirals and Hepatocellular Carcinoma RecurrenceCompletedNCT03197155
• Ribavirin Bioavailability After Telaprevir ExposureCompletedNCT02881034
• Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple TherapyCompletedNCT02877199
• HCV Virions Bound ProteinsCompletedNCT02795403Not applicable
• Role of FXR in Hepatitis C Virus ReplicationTerminatedNCT01492998Not applicable
• RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of RibavirinStatus unknownNCT00485342Phase 3